Larkina M. S. Mariya Sergeevna, Varvashenya R. N. Ruslan Nikolaevich, Yuldasheva F. Sh. Feruza Sherzod kizi, Plotnikov E. V. Evgeny Vladimirovich, Bezverkhniaia E. A. Ekaterina Aleksandrovna, Tretyakova M. S. Maria Sergeevna, . . . Deev S. M. Sergey Mikhaylovich. (2024). Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4. 2024. https://doi.org/10.1021/acs.molpharmaceut.3c01173
Chicago Style (17th ed.) CitationLarkina M. S. Mariya Sergeevna, et al. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, Iss. 4. 2024, 2024. https://doi.org/10.1021/acs.molpharmaceut.3c01173.
MLA (9th ed.) CitationLarkina M. S. Mariya Sergeevna, et al. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, Iss. 4. 2024, 2024. https://doi.org/10.1021/acs.molpharmaceut.3c01173.